deutsch english

Function as information officer

How far are pharmaceutical companies allowed to go when advertising medicinal products? Is the patient information leaflet hard to understand because complex but relevant information is missing? What must and what may a summary of product characteristics contain? Diapharm is fully acquainted with these issues – and also takes responsibility for them: as the information officer in acc. with Section 74a of the German Drug Law (AMG), we provide you with expert and reliable assistance regarding questions relating to drug information.

For example we check:

  • Label texts
  • Patient information leaflets
    (PIL)
  • Summary of product characteristics
    (SmPC)
  • Advertising materials
    (adverts, brochures, displays, etc.)

Your benefits

  • Guaranteed compliance with the laws regulating healthcare advertising
  • No commitment of personnel
  • Qualified specialists to serve in this capacity
In addition to the simple review of provided texts, Diapharm, as an information officer in accordance with Section 74a of the AMG, naturally also offers medical writing services for technical information texts with the technical knowledge necessary for this job.
News
API GMP audit reports >> more